154 related articles for article (PubMed ID: 34220320)
1. Enhancement of cytotoxicity and induction of apoptosis by cationic nano-liposome formulation of
Huang XF; Chang KF; Lin YL; Liao KW; Hsiao CY; Sheu GT; Tsai NM
Int J Med Sci; 2021; 18(13):2930-2942. PubMed ID: 34220320
[TBL] [Abstract][Full Text] [Related]
2. Antitumor Effect of
Gao HW; Chang KF; Huang XF; Lin YL; Weng JC; Liao KW; Tsai NM
Molecules; 2018 Dec; 23(12):. PubMed ID: 30563276
[TBL] [Abstract][Full Text] [Related]
3. Encapsulated
Lin YL; Huang XF; Chang KF; Liao KW; Tsai NM
Int J Nanomedicine; 2020; 15():749-760. PubMed ID: 32099363
[TBL] [Abstract][Full Text] [Related]
4. Liposomal n-butylidenephthalide protects the drug from oxidation and enhances its antitumor effects in glioblastoma multiforme.
Lin YL; Chang KF; Huang XF; Hung CL; Chen SC; Chao WR; Liao KW; Tsai NM
Int J Nanomedicine; 2015; 10():6009-20. PubMed ID: 26451107
[TBL] [Abstract][Full Text] [Related]
5. Antitumor Effects of
Chang KF; Chang JT; Huang XF; Lin YL; Liao KW; Huang CW; Tsai NM
Molecules; 2020 May; 25(10):. PubMed ID: 32455622
[TBL] [Abstract][Full Text] [Related]
6. Enhanced anticancer activity and endocytic mechanisms by polymeric nanocarriers of n-butylidenephthalide in leukemia cells.
Huang XF; Chen PT; Lin YL; Lee MS; Chang KF; Liao KW; Sheu GT; Hsieh MC; Tsai NM
Clin Transl Oncol; 2021 Jun; 23(6):1142-1151. PubMed ID: 32989675
[TBL] [Abstract][Full Text] [Related]
7. Positively Charged Nanoparticle Delivery of n-Butylidenephthalide Enhances Antitumor Effect in Hepatocellular Carcinoma.
Chang KF; Huang XF; Lin YL; Liao KW; Hsieh MC; Chang JT; Tsai NM
Biomed Res Int; 2021; 2021():8817875. PubMed ID: 33791383
[TBL] [Abstract][Full Text] [Related]
8. A Lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells.
Lin YL; Liu YK; Tsai NM; Hsieh JH; Chen CH; Lin CM; Liao KW
Nanomedicine; 2012 Apr; 8(3):318-27. PubMed ID: 21704596
[TBL] [Abstract][Full Text] [Related]
9. Specific drug delivery efficiently induced human breast tumor regression using a lipoplex by non-covalent association with anti-tumor antibodies.
Lin YL; Tsai NM; Chen CH; Liu YK; Lee CJ; Chan YL; Wang YS; Chang YC; Lin CH; Huang TH; Wang CC; Chi KH; Liao KW
J Nanobiotechnology; 2019 Feb; 17(1):25. PubMed ID: 30728015
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplex.
Lin YL; Chen CH; Wu HY; Tsai NM; Jian TY; Chang YC; Lin CH; Wu CH; Hsu FT; Leung TK; Liao KW
J Nanobiotechnology; 2016 Feb; 14():11. PubMed ID: 26892504
[TBL] [Abstract][Full Text] [Related]
11. Improved Delivery Performance of n-Butylidenephthalide-Polyethylene Glycol-Gold Nanoparticles Efficient for Enhanced Anti-Cancer Activity in Brain Tumor.
Hsing MT; Hsu HT; Chang CH; Chang KB; Cheng CY; Lee JH; Huang CL; Yang MY; Yang YC; Liu SY; Yen CM; Yang SF; Hung HS
Cells; 2022 Jul; 11(14):. PubMed ID: 35883615
[TBL] [Abstract][Full Text] [Related]
12. Liposomes co-encapsulating doxorubicin and glucoevatromonoside derivative induce synergic cytotoxic response against breast cancer cell lines.
Novais MVM; Gomes ER; Miranda MC; Silva JO; Gomes DA; Braga FC; Pádua RM; Oliveira MC
Biomed Pharmacother; 2021 Apr; 136():111123. PubMed ID: 33486211
[TBL] [Abstract][Full Text] [Related]
13. Anti-Tumor and Radiosensitization Effects of N-Butylidenephthalide on Human Breast Cancer Cells.
Su YJ; Huang SY; Ni YH; Liao KF; Chiu SC
Molecules; 2018 Jan; 23(2):. PubMed ID: 29370116
[No Abstract] [Full Text] [Related]
14. Lipo-PEG-PEI complex as an intracellular transporter for protein therapeutics.
Lin YL; Chen CH; Liu YK; Huang TH; Tsai NM; Tzou SC; Liao KW
Int J Nanomedicine; 2019; 14():1119-1130. PubMed ID: 30863049
[TBL] [Abstract][Full Text] [Related]
15. Potential therapeutic effects of N-butylidenephthalide from Radix Angelica Sinensis (Danggui) in human bladder cancer cells.
Chiu SC; Chiu TL; Huang SY; Chang SF; Chen SP; Pang CY; Hsieh TF
BMC Complement Altern Med; 2017 Dec; 17(1):523. PubMed ID: 29207978
[TBL] [Abstract][Full Text] [Related]
16. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
[TBL] [Abstract][Full Text] [Related]
17. Nano-assemblies of J-aggregates based on a NIR dye as a multifunctional drug carrier for combination cancer therapy.
Song X; Zhang R; Liang C; Chen Q; Gong H; Liu Z
Biomaterials; 2015 Jul; 57():84-92. PubMed ID: 25913253
[TBL] [Abstract][Full Text] [Related]
18. Liposome-based polymer complex as a novel adjuvant: enhancement of specific antibody production and isotype switch.
Chen CH; Lin YL; Liu YK; He PJ; Lin CM; Chiu YH; Wu CJ; Cheng TL; Liu SJ; Liao KW
Int J Nanomedicine; 2012; 7():607-21. PubMed ID: 22346354
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
Hou W; Chen L; Yang G; Zhou H; Jiang Q; Zhong Z; Hu J; Chen X; Wang X; Yuan Y; Tang M; Wen J; Wei Y
Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic insight into salinomycin mechanisms in breast cancer cell lines: synergistic effects with dasatinib and induction of estrogen receptor β.
Bellat V; Verchère A; Ashe SA; Law B
BMC Cancer; 2020 Jul; 20(1):661. PubMed ID: 32678032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
